RxDoctor Payments Data

Doriann Stempinski

Family · Albany, GANPI 1417477811

Payments from drug & device makers

$7,319in general payments, 2019–2025

Across 314 payments — averaging $23.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$982
  • AstraZeneca$776
  • Amgen$558
  • Dexcom, Inc.$494
  • Novo Nordisk$399
  • Lilly USA, LLC$391
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$7,319100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,319 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$16,448
OzempicSemaglutide12$12,850
EliquisApixaban22$12,795
Atorvastatin Calcium51$1,020
Albuterol Sulfate HfaAlbuterol Sulfate43$810
Quetiapine Fumarate15$535
Hydralazine Hcl29$531
Metoprolol Succinate31$523
Gabapentin27$509
Potassium Chloride16$455
Donepezil Hcl32$448
Diclofenac Sodium12$399
Duloxetine Hcl23$367
Tamsulosin Hcl15$352
Dutasteride11$335

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$982$16,44812 claims
Novo NordiskOzempic$399$12,85012 claims
PfizerEliquis$286$12,79522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.

Other family in Albany

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →